Expand ELAN Menu
ELAN MENU

ELAN Latest Press Releases

-- February 13, 2026 --

Elanco Announces Updates to Board of Directors PRNewswire 9:25 AM

-- February 5, 2026 --

Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of DICK's Sporting Goods, Inc. (DKS), Domino's Pizza, Inc. (DPZ), Elanco Animal Health Incorporated (ELAN), and Elevance Health, Inc. (ELV) Globe Newswire 10:46 AM

-- January 22, 2026 --

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement PRNewswire 8:00 AM

-- January 6, 2026 --

Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference PRNewswire 8:00 AM

-- December 31, 2025 --

Elanco Receives USDA Approval for Befrena (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis PRNewswire 2:00 PM

-- December 18, 2025 --

Elanco's Credelio Quattro -CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs PRNewswire 8:43 AM

-- December 9, 2025 --

Elanco Investor Day Defines New Era as Sustainable Growth Company PRNewswire 7:40 AM

-- November 26, 2025 --

Elanco executive appointed as Neurizon's Board Observer PRNewswire 6:16 PM

-- November 21, 2025 --

Elanco's Credelio CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats PRNewswire 1:36 PM

-- November 20, 2025 --

Elanco to Participate in the Upcoming Investor Conferences PRNewswire 8:00 AM

-- November 13, 2025 --

Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health PRNewswire 8:00 AM

-- November 5, 2025 --

Elanco Animal Health Reports Third Quarter 2025 Results PRNewswire 6:27 AM

-- October 27, 2025 --

Elanco Announces Expansion of Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species PRNewswire 6:27 AM

-- October 24, 2025 --

Elanco's Credelio (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs PRNewswire 4:55 PM

-- October 16, 2025 --

Elanco to Host Investor Day on December 9 PRNewswire 4:32 PM

-- October 1, 2025 --

Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement PRNewswire 8:02 AM

-- September 23, 2025 --

Elanco Announces FDA Approves Improved Zenrelia (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language PRNewswire 6:27 AM
Market Data Delayed 15 Minutes